Close

Nymox Announces New Marketing Submission For NYMOZARFEX For BPH

Published on December 05, 2022 09:45 AM EST

Dec 5 (Reuters) - Nymox Pharmaceutical Corp:

* NYMOX ANNOUNCES NEW MARKETING SUBMISSION FOR NYMOZARFEX™ FOR BPH

* NYMOX PHARMACEUTICAL CORP - ANNOUNCE A NEW FORMAL SUBMISSION HAS BEEN MADE IN EUROPE FOR FEXAPOTIDE TRIFLUTATE FOR TREATMENT BPH

* NYMOX PHARMACEUTICAL CORP - MARKETING AUTHORIZATION APPLICATION (MAA) WAS SUBMITTED TO DANISH AUTHORITIES Source text for Eikon: Further company coverage:

Reuters

Reuters -
90249 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.